Sorrento Therapeutics, Inc.
SRNEDelisted Apr 12, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000850261
Sorrento Therapeutics, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 20, 2023; 224 institutions reported holding it in 13F filings for Q4 2022, worth $180.7M in total; Oaktree Capital was the only superinvestor holding it.
Holders of 5% or more of SRNE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sorrento Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Sorrento Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Sorrento Therapeutics, Inc., newest first.
No Schedule 13D or 13G filings on Sorrento Therapeutics, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Sorrento Therapeutics, Inc. shares.
No Form 144 notices for Sorrento Therapeutics, Inc. are on file.